China Oncology ›› 2016, Vol. 26 ›› Issue (1): 1-12.doi: 10.3969/j.issn.1007-3969.2016.01.001

Previous Articles     Next Articles

The interpretation of 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Carcinoma: New progress in radioactive iodine therapy of differentiated thyroid carcinoma

LIN Yansong1, LI Jiao1,2   

  1. 1. Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China; 2. Department of Oncology, the Affiliated Hospital of Qingdao University, Qingdao 266003, Shandong Province, China
  • Online:2016-01-30 Published:2016-02-26
  • Contact: LIN Yansong E-mail: linys@pumch.cn

Abstract: Recently, the morbidity of differentiated thyroid carcinoma (DTC) has increased annually. American Thyroid Association (ATA) published the management guidelines for patients with thyroid nodules and DTC in 2006 in order to standardize their management. The ATA guidelines was updated for the first time in 2009 and its renewed version was completed in 2015 based on the considerable progress that had been made in the fields such as diagnostic assessment and management of thyroid nodules, surgery and radioactive iodine therapy for DTC in recent years. This article tried to interpret the updated contents about radioactive iodine therapy for DTC in 2015 version of the guidelines.

Key words: 2015 version of American Thyroid Association Guidelines, Differentiated thyroid carcinoma, Radioactive iodine therapy, Research progress